[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583815":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":28,"locations":37,"responsibleParty":63,"collaborators":10,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":10,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":10,"enrollmentInfo":75,"targetDuration":10,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":83,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"IBD patients with positive HBV infection.",null,"81 IBD patients with positive HBV infection.",[13],"Other: History of IBD course and outcome in HBV patients",{"label":15,"type":10,"description":16,"interventionNames":17},"IBD Patients with negative HBV infection","81 IBD Patients with negative HBV infection",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"History of IBD course and outcome in HBV patients","Full history taking including:\n\n* Personal history (name, age, sex, occupation, residence, and marital state).\n* Complaint.\n* Age at diagnosis of IBD.\n* Medication history.\n* History of hospital admissions and disease flares.\n* Disease extent, location, and behavior. (Montreal classification, Truelove-Witts severity index).\n* Surgical history (intestinal resection in CD patients and total proctocolectomy in UC patients).\n* Follow up duration and mortality.\n* Data of endoscopic examination\n* Data of laboratory investigations (complete blood picture, HBV serology, liver and kidney function tests, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP)).",[15,9],[24],{"name":25,"affiliation":26,"role":27},"Nabila A Elgazzar, MD","Tropical medicine and infectious diseases Department, Faculty of Medicine, Tanta University","STUDY_DIRECTOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Rania M Elkafoury, MD","CONTACT","+201004672358","rania.elkafoury@med.tanta.edu.eg",{"name":25,"role":31,"phone":35,"phoneExt":10,"email":36},"00201288585733","nabilaelgazzar@med.tanta.edu.eg",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Tanta University Hospitals","RECRUITING","Tanta","Gharbyea","31516","Egypt","EG",{"type":47,"coordinates":48},"Point",[49,50],31.00192,30.78847,{"lat":50,"lon":49},[53,57,59,62],{"name":54,"role":31,"phone":55,"phoneExt":10,"email":56},"Dina H Ziada, MD","00201117109990","dina.ziada@med.tanta.edu.eg",{"name":25,"role":58,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":60,"role":61,"phone":10,"phoneExt":10,"email":10},"Amal M Dwidar, MD","SUB_INVESTIGATOR",{"name":30,"role":61,"phone":10,"phoneExt":10,"email":10},{"type":58,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Rania Mamdouh Elkafoury","Lecturer of Tropical Medicine","100583815","impact-of-hepatitis-b-virus-on-inflammatory-bowel-disease-100583815",false,"NCT06881238","Impact of Hepatitis B Virus on Inflammatory Bowel Disease","The Impact of Hepatitis B Virus Infection on the Clinical Course of Inflammatory Bowel Disease in Egyptian Patients","Inclusion Criteria:\n\n* Male or female patients older than 18 years.\n* Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria.\n\nExclusion Criteria:\n\n* Patients aged \\\u003C 18 years\n* Unwilling to participate in our study","ALL","18 Years",{"count":76,"type":77},162,"ESTIMATED","OBSERVATIONAL","The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients.\n\nResearchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection.\n\nParticipants will be subjected to history-taking (history of hospital admission and disease flare, surgical history, medication history, follow-up duration, and mortality), clinical examination, laboratory investigations, abdominal ultrasonography, and endoscopic examination.",[81,82],"Inflammatory Bowel Disease (IBD)","Hepatitis B Virus",[84,85],"Hepatitis b virus","Inflammatory bowel disease course","2025-03-11",{"date":88,"type":89},"2025-03-18","ACTUAL",{"date":91,"type":89},"2024-12-01",{"date":93,"type":77},"2025-06-10",{"name":5,"class":6},1]